Rebecca L King (R L King)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 27

Top Topics

Decision Making

Newly Diagnosed

Diffuse Large B Cell Lymphoma

Top Venues

Blood cancer journal

Journal of hematopathology

JCO oncology practice

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Marie-France Gagnon, Frido K Bruehl, Daniel R Sill, Reid G Meyer, Patricia T Greipp, Nicole L Hoppman, Xinjie Xu, Linda B Baughn, Jess F Peterson, Ellen D McPhail, Rhett P Ketterling, Rebecca L King
Cytogenetic and pathologic characterization of MYC-rearranged B-cell lymphomas in pediatric and young adult patients. Journal of hematopathology 17 (2) (2024)
Marie-France Gagnon, Frido K Bruehl, Daniel R Sill, Reid G Meyer, Patricia T Greipp, Nicole L Hoppman, Xinjie Xu, Linda B Baughn, Jess F Peterson, Ellen D McPhail, Rhett P Ketterling, Rebecca L King
Cytogenetic and pathologic characterization of MYC-rearranged B-cell lymphomas in pediatric and young adult patients. Journal of hematopathology 17 (2) (2024)
Kerstin Wenzl, Matthew E Stokes, Joseph P Novak, Allison M Bock, Sana Khan, Melissa A Hopper, Jordan Edward Krull, Abigail R Dropik, Janek S Walker, Vivekananda Sarangi, Raphael Mwangi, Maria Ortiz, Nicholas Stong, C Chris Huang, Matthew John Maurer, Lisa Rimsza, Brian K Link, Susan L Slager, Yan Asmann, Patrizia Mondello, Ryan Morin, Stephen M Ansell, Thomas M Habermann, Thomas E Witzig, Andrew L Feldman, Rebecca L King, Grzegorz S Nowakowski, James R Cerhan, Anita K Gandhi, Anne J Novak
Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL. Blood cancer journal 14 (1) (2024)
Marie-France Gagnon, Frido K Bruehl, Daniel R Sill, Reid G Meyer, Patricia T Greipp, Nicole L Hoppman, Xinjie Xu, Linda B Baughn, Jess F Peterson, Ellen D McPhail, Rhett P Ketterling, Rebecca L King
Cytogenetic and pathologic characterization of MYC-rearranged B-cell lymphomas in pediatric and young adult patients. Journal of hematopathology (2024)
Chonlada Laoruangroj, Thomas M Habermann, Yucai Wang, Rebecca L King, Scott C Lester, Carrie A Thompson, Thomas E Witzig
Should All Patients With Stage IE Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Receive Antibiotic Eradication Therapy for Helicobacter pylori ? JCO oncology practice (2024)
Chonlada Laoruangroj, Thomas M Habermann, Yucai Wang, Rebecca L King, Scott C Lester, Carrie A Thompson, Thomas E Witzig
Should All Patients With Stage IE Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Receive Antibiotic Eradication Therapy for Helicobacter pylori ? JCO oncology practice 20 (8) (2024)
Marie-France Gagnon, Frido K Bruehl, Daniel R Sill, Reid G Meyer, Patricia T Greipp, Nicole L Hoppman, Xinjie Xu, Linda B Baughn, Jess F Peterson, Ellen D McPhail, Rhett P Ketterling, Rebecca L King
Cytogenetic and pathologic characterization of MYC-rearranged B-cell lymphomas in pediatric and young adult patients. Journal of hematopathology 17 (2) (2024)
Marie-France Gagnon, Frido K Bruehl, Daniel R Sill, Reid G Meyer, Patricia T Greipp, Nicole L Hoppman, Xinjie Xu, Linda B Baughn, Jess F Peterson, Ellen D McPhail, Rhett P Ketterling, Rebecca L King
Cytogenetic and pathologic characterization of MYC-rearranged B-cell lymphomas in pediatric and young adult patients. Journal of hematopathology 17 (2) (2024)
Kerstin Wenzl, Matthew E Stokes, Joseph P Novak, Allison M Bock, Sana Khan, Melissa A Hopper, Jordan Edward Krull, Abigail R Dropik, Janek S Walker, Vivekananda Sarangi, Raphael Mwangi, Maria Ortiz, Nicholas Stong, C Chris Huang, Matthew John Maurer, Lisa Rimsza, Brian K Link, Susan L Slager, Yan Asmann, Patrizia Mondello, Ryan Morin, Stephen M Ansell, Thomas M Habermann, Thomas E Witzig, Andrew L Feldman, Rebecca L King, Grzegorz S Nowakowski, James R Cerhan, Anita K Gandhi, Anne J Novak
Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL. Blood cancer journal 14 (1) (2024)
Marie-France Gagnon, Frido K Bruehl, Daniel R Sill, Reid G Meyer, Patricia T Greipp, Nicole L Hoppman, Xinjie Xu, Linda B Baughn, Jess F Peterson, Ellen D McPhail, Rhett P Ketterling, Rebecca L King
Cytogenetic and pathologic characterization of MYC-rearranged B-cell lymphomas in pediatric and young adult patients. Journal of hematopathology 17 (2) (2024)
Chonlada Laoruangroj, Thomas M Habermann, Yucai Wang, Rebecca L King, Scott C Lester, Carrie A Thompson, Thomas E Witzig
Should All Patients With Stage IE Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Receive Antibiotic Eradication Therapy for Helicobacter pylori ? JCO oncology practice 20 (8) (2024)
Kerstin Wenzl, Matthew E Stokes, Joseph P Novak, Allison M Bock, Sana Khan, Melissa A Hopper, Jordan Edward Krull, Abigail R Dropik, Janek S Walker, Vivekananda Sarangi, Raphael Mwangi, Maria Ortiz, Nicholas Stong, C Chris Huang, Matthew John Maurer, Lisa Rimsza, Brian K Link, Susan L Slager, Yan Asmann, Patrizia Mondello, Ryan Morin, Stephen M Ansell, Thomas M Habermann, Thomas E Witzig, Andrew L Feldman, Rebecca L King, Grzegorz S Nowakowski, James R Cerhan, Anita K Gandhi, Anne J Novak
Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL. Blood cancer journal 14 (1) (2024)
Kerstin Wenzl, Matthew E Stokes, Joseph P Novak, Allison M Bock, Sana Khan, Melissa A Hopper, Jordan Edward Krull, Abigail R Dropik, Janek S Walker, Vivekananda Sarangi, Raphael Mwangi, Maria Ortiz, Nicholas Stong, C Chris Huang, Matthew John Maurer, Lisa Rimsza, Brian K Link, Susan L Slager, Yan Asmann, Patrizia Mondello, Ryan Morin, Stephen M Ansell, Thomas M Habermann, Thomas E Witzig, Andrew L Feldman, Rebecca L King, Grzegorz S Nowakowski, James R Cerhan, Anita K Gandhi, Anne J Novak
Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL. Blood cancer journal 14 (1) (2024)
Marie-France Gagnon, Alan R Penheiter, Faye Harris, Dorsay Sadeghian, Sarah H Johnson, Giannoula Karagouga, Alexa McCune, Cinthya Zepeda-Mendoza, Patricia T Greipp, Xinjie Xu, Rhett P Ketterling, Ellen Darcy McPhail, Rebecca L King, Jess F Peterson, George Vasmatzis, Linda B Baughn
Unraveling the genomic underpinnings of unbalanced MYC break-apart FISH results using whole genome sequencing analysis. Blood cancer journal 13 (1) (2023)
Marie-France Gagnon, Alan R Penheiter, Faye Harris, Dorsay Sadeghian, Sarah H Johnson, Giannoula Karagouga, Alexa McCune, Cinthya Zepeda-Mendoza, Patricia T Greipp, Xinjie Xu, Rhett P Ketterling, Ellen Darcy McPhail, Rebecca L King, Jess F Peterson, George Vasmatzis, Linda B Baughn
Unraveling the genomic underpinnings of unbalanced MYC break-apart FISH results using whole genome sequencing analysis. Blood cancer journal 13 (1) (2023)
Marie-France Gagnon, Alan R Penheiter, Faye Harris, Dorsay Sadeghian, Sarah H Johnson, Giannoula Karagouga, Alexa McCune, Cinthya Zepeda-Mendoza, Patricia T Greipp, Xinjie Xu, Rhett P Ketterling, Ellen Darcy McPhail, Rebecca L King, Jess F Peterson, George Vasmatzis, Linda B Baughn
Unraveling the genomic underpinnings of unbalanced MYC break-apart FISH results using whole genome sequencing analysis. Blood cancer journal 13 (1) (2023)
Marie-France Gagnon, Alan R Penheiter, Faye Harris, Dorsay Sadeghian, Sarah H Johnson, Giannoula Karagouga, Alexa McCune, Cinthya Zepeda-Mendoza, Patricia T Greipp, Xinjie Xu, Rhett P Ketterling, Ellen Darcy McPhail, Rebecca L King, Jess F Peterson, George Vasmatzis, Linda B Baughn
Unraveling the genomic underpinnings of unbalanced MYC break-apart FISH results using whole genome sequencing analysis. Blood cancer journal 13 (1) (2023)
Marie-France Gagnon, Alan R Penheiter, Faye Harris, Dorsay Sadeghian, Sarah H Johnson, Giannoula Karagouga, Alexa McCune, Cinthya Zepeda-Mendoza, Patricia T Greipp, Xinjie Xu, Rhett P Ketterling, Ellen Darcy McPhail, Rebecca L King, Jess F Peterson, George Vasmatzis, Linda B Baughn
Unraveling the genomic underpinnings of unbalanced MYC break-apart FISH results using whole genome sequencing analysis. Blood cancer journal 13 (1) (2023)
Laurence L de Leval, Ash A Alizadeh, Peter Leif Bergsagel, Elias Campo, Andrew John Davies, Ahmet Dogan, Jude Fitzgibbon, Steven M Horwitz, Ari M Melnick, William George Morice, Ryan D Morin, Bertrand Nadel, Stefano A Pileri, Richard Rosenquist, Davide Rossi, Itziar Salaverria, Christian Steidl, Steven P Treon, Andrew D Zelenetz, Ranjana H Advani, Carl E Allen, Stephen M Ansell, Wing C John Chan, James R Cook, Lucy B M Cook, Francesco d'Amore, Stefan Dirnhofer, Martin Dreyling, Kieron Dunleavy, Andrew L Feldman, Falko Fend, Philippe Gaulard, Paolo Ghia, John G Gribben, Olivier Hermine, Daniel James Hodson, Eric D Hsi, Giorgio Ga Inghirami, Elaine S Jaffe, Kennosuke Karube, Keisuke Kataoka, Wolfram Klapper, Won Seog Kim, Rebecca L King, Young-Hyeh Ko, Ann Steward LaCasce, Georg Lenz, José I Martin-Subero, Miguel Angel Piris, Stefania Pittaluga, Laura Pasqualucci, Leticia Quintanilla-Fend, Scott J Rodig, Andreas Rosenwald, Gilles Andre Salles, Jesús San F Miguel, Kerry Joane Savage, Laurie Helen Sehn, Gianpietro C Semenzato, Louis M Staudt, Steven Howard Swerdlow, Constantine S Tam, Judith Trotman, Julie M Vose, Oliver Weigert, Wyndham H Wilson, Jane N Winter, Catherine J Wu, Pier Luigi Luigi Zinzani, Emanuele Zucca, Adam Bagg, David W Scott
Genomic profiling for clinical decision making in lymphoid neoplasms. Blood 140 (21) (2022)
Rebecca L King, Alia Gupta, Paul J Kurtin, Wei Ding, Timothy G Call, Kari G Rabe, Saad Sirop Kenderian, Jose F Leis, Yucai Wang, Susan M Schwager, Susan L Slager, Neil E Kay, Amber Koehler, Stephen M Ansell, David J Inwards, Thomas M Habermann, Min Shi, Curtis A Hanson, Matthew T Howard, Sameer A Parikh
Chronic lymphocytic leukemia (CLL) with Reed-Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter? Blood cancer journal 12 (1) (2022)
Sanjal H Desai, Levi D Pederson, Betsy LaPlant, Raphael Mwangi, Matthew John Maurer, Jason R Young, William R Macon, Rebecca L King, Yucai Wang, James R Cerhan, Andrew L Feldman, David J Inwards, Ivana Micallef, Patrick Johnston, Luis F Porrata, Stephen M Ansell, Thomas M Habermann, Thomas E Witzig, Grzegorz S Nowakowski
PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohorts. Blood cancer journal 12 (5) (2022)
null Arushi Khurana, Raphael Mwangi, Stephen M Ansell, Thomas M Habermann, James R Cerhan, Christopher Strouse, Brian K Link, Yucai Wang, Rebecca L King, William R Macon, Jose C Villasboas Bisneto, Thomas E Witzig, Matthew John Maurer, Grzegorz S Nowakowski
Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab era. Blood cancer journal 11 (7) (2021)
Grzegorz S Nowakowski, Fangxin Hong, David W Scott, William R Macon, Rebecca L King, Thomas M Habermann, Nina Wagner-Johnston, Carla Casulo, James L Wade, Gauri G Nagargoje, C M Reynolds, Jonathon B Cohen, Nadia Khan, Jennifer Effie Amengual, Kristy L Richards, Richard F Little, John P Leonard, Jonathan W Friedberg, Lale Kostakoglu, Brad S Kahl, Thomas E Witzig
Addition of Lenalidomide to R-CHOP Improves Outcomes in Newly Diagnosed Diffuse Large B-Cell Lymphoma in a Randomized Phase II US Intergroup Study ECOG-ACRIN E1412. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (12) (2021)
Priyanka A Pophali, Lisa M Marinelli, Rhett P Ketterling, Reid G Meyer, Ellen D McPhail, Paul J Kurtin, Raphael Mwangi, Matthew John Maurer, Thomas Habermann, Rebecca L King
High level MYC amplification in B-cell lymphomas: is it a marker of aggressive disease? Blood cancer journal 10 (1) (2020)
Jithma P Abeykoon, Jonas Paludo, Kevin E Nowakowski, Mary J Stenson, Rebecca L King, Linda E Wellik, Xiaosheng Wu, Thomas E Witzig
The effect of CRM1 inhibition on human non-Hodgkin lymphoma cells. Blood cancer journal 9 (3) (2019)
A Castellino, A Chiappella, B R LaPlant, Levi D Pederson, G Gaidano, W R Macon, G Inghirami, C B Reeder, A Tucci, Rebecca L King, A Congiu, J M Foran, V Pavone, C E Rivera, M Spina, S M Ansell, F Cavallo, A L Molinari, Giovannino Ciccone, T M Habermann, T E Witzig, U Vitolo, G S Nowakowski
Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials. Blood cancer journal 8 (11) (2018)
Rebecca L King, Grzegorz S Nowakowski, Thomas E Witzig, David W Scott, Richard F Little, Fangxin Hong, Randy D Gascoyne, Brad S Kahl, William R Macon
Rapid, real time pathology review for ECOG/ACRIN 1412: a novel and successful paradigm for future lymphoma clinical trials in the precision medicine era. Blood cancer journal 8 (3) (2018)